![Theresa Heggie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Theresa Heggie
Directeur/Membre du Conseil chez
BIOCRYST PHARMACEUTICALS, INC.
Fortune : 787 480 $ au 31/05/2026
Profil
Ms. Theresa M.
Heggie is an Independent Director at BioCryst Pharmaceuticals, Inc. and a Co-Managing Director at Alnylam Germany GmbH.
She is on the Board of Directors at ProQR Therapeutics NV, BioCryst Pharmaceuticals, Inc. and Alnylam UK Ltd. Ms. Heggie was previously employed as a Chief Executive Officer & Director by Freeline Therapeutics Holdings Ltd., a Senior Vice President, Head-EMEA & Canada Region by Alnylam Pharmaceuticals, Inc., an Independent Non-Executive Director by Swedish Orphan Biovitrum AB, a Chief Marketing & Strategy Officer by The British United Provident Association Ltd., a Senior Vice President-Global Commercial Operations by TRANSKARYOTIC THERAPIES INC, a Chief Executive Officer by Jerini AG, a Senior Vice President-Global Commercial Operations by Shire Plc, a Vice President-Global Marketing by Baxter International, Inc., a Principal by Janssen Pharmaceuticals, Inc., a Principal by Ohmeda Pharmaceuticals, and a Chief Executive Officer by Spur Therapeutics Ltd. She received her undergraduate degree from Cornell University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 80 646 ( 0,03 % ) | 718 556 $ | 31/05/2026 | |
PROQR THERAPEUTICS N.V. 0,04 % | 18/03/2026 | 43 623 ( 0,04 % ) | 68 924 $ | 31/05/2026 |
Postes actifs de Theresa Heggie
| Sociétés | Poste | Début |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 03/12/2018 |
| PROQR THERAPEUTICS N.V. | Directeur/Membre du Conseil | 18/05/2023 |
Alnylam Germany GmbH
 Alnylam Germany GmbH BiotechnologyHealth Technology Engages in research, development, manufacturing and distribution of pharmaceutical products | Directeur Général | - |
Alnylam UK Ltd.
 Alnylam UK Ltd. BiotechnologyHealth Technology Develops biotechnology products | Directeur/Membre du Conseil | 09/10/2017 |
Anciens postes connus de Theresa Heggie
| Sociétés | Poste | Fin |
|---|---|---|
| FREELINE THERAPEUTICS HOLDINGS PLC | Directeur Général | 15/08/2021 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2020 |
| SWEDISH ORPHAN BIOVITRUM AB | Directeur/Membre du Conseil | 10/04/2017 |
The British United Provident Association Ltd.
 The British United Provident Association Ltd. Life/Health InsuranceFinance Provides health insurance and consulting, dental & aged care services | Sales & Marketing | 01/03/2016 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Corporate Officer/Principal | 01/05/2013 |
Formation de Theresa Heggie
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
The British United Provident Association Ltd.
The British United Provident Association Ltd. Life/Health InsuranceFinance Provides health insurance and consulting, dental & aged care services | Finance |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs | Health Technology |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Health Technology |
Ohmeda Pharmaceuticals | |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
ProQR Therapeutics NV
 ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which developing gene therapies for bleeding and other debilitating disorders | Health Technology |
Alnylam Germany GmbH
Alnylam Germany GmbH BiotechnologyHealth Technology Engages in research, development, manufacturing and distribution of pharmaceutical products | Health Technology |
Alnylam UK Ltd.
Alnylam UK Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Develops and manufactures next-generation gene therapies | Health Technology |
